Interferon-β May Treat Primary Sjögren’s Patients by Easing Inflammation, Study Finds
Treatment with interferon-beta (IFN-β) reduces the inflammatory response in immune cells from Sjögren’s syndrome patients, a study reports. The findings suggest that treatment with IFN-β may be a potential way of controlling inflammation in Sjögren’s patients. The study, “…